In systemic lupus erythematosus (SLE), RFX1 downregulated IL17A, CD70, and CD11a expression by recruiting DNMT1, HDAC1, and SUV39H1 to alter epigenetic modifications in CD4+ T cells from patients with lupus [28, 44]. The gene discussed is IL17A; the disease is systemic lupus erythematosus.